Drugs / T-DEN F17
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00370682 | Apr 2007 → Feb 2008 | dengue disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T-DEN F17 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00370682 ↗ |
| Modality | Vaccine | “live-attenuated tetravalent dengue virus (TDEN) vaccine” PMID 24865677 ↗ May 2014 |
| Route | Subcutaneous | “injected subcutaneously into the upper-outer triceps/deltoid area of the non-dominant arm” NCT00370682 ↗ |